ARS Pharmaceuticals, Inc. (SPRY) P/E ratio

PE ratio:

N/A
September 12, 2025

Summary

  • SPRY price to earnings ratio is not available.

Performance

SPRY PE ratio Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

OtherSPRYvaluation metrics

PE ratio Formula

P/E =  
Price
TTM Earnings Per Share

SPRY PE ratio Trends

PeriodPeriodPE ratioPE ratioPricePriceTTM EPSTTM EPSTTM revenueTTM revenue
todaytoday--1.2%-194.1%+15.7%
1 m1 month--39.8%--
3 m3 months--30.4%-194.1%+15.7%
6 m6 months--18.5%--
ytdytd--4.9%--
1 y1 year--20.6%-6.4%+10000.0%
5 y5 years---100.0%+100.0%

SPRY PE ratio Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month
3 m3-month
6 m6-month204.43163.43
1 y1-year212.57145.43
3 y3-year212.57145.43
5 y5-year212.57145.43
alltimeall time212.57145.43

SPRY PE ratio History

DateValue
DateValue
2024
150.71

FAQ

  • What is the all time high PE ratio for ARS Pharmaceuticals, Inc.?

What is the all time high PE ratio for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high price to earnings ratio is 212.57
On this page